![Alon Ben-Noon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alon Ben-Noon
Fondateur chez
NEUROSENSE THERAPEUTICS LTD.
Fortune : 105 421 $ au 31/07/2026
Profil
Alon Ben-Noon founded Neurosense Therapeutics Ltd. in 2017, where he is working as Chief Executive Officer & Director from 2021 and Medican Consulting in 2014, where he worked as Owner from 2014 to 2017.
Mr. Ben-Noon received his undergraduate degree and Masters Business Admin degree from Ben-Gurion University of the Negev.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/06/2026 | 226 712 ( 0,64% ) | 105 421 $ | 31/07/2026 |
Postes actifs de Alon Ben-Noon
| Sociétés | Poste | Début |
|---|---|---|
| NEUROSENSE THERAPEUTICS LTD. | Fondateur | 13/02/2017 |
Anciens postes connus de Alon Ben-Noon
| Sociétés | Poste | Fin |
|---|---|---|
Medican Consulting | Fondateur | 01/01/2017 |
Formation de Alon Ben-Noon
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
19
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Ben-Gurion University of the Negev
 Ben-Gurion University of the Negev Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neurosense Therapeutics Ltd.
 Neurosense Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage drug development company | Health Technology |
Medican Consulting |
